Familial segregation of a VSX1 mutation adds a new dimension to its role in the causation of keratoconus by Paliwal, Preeti et al.
Familial segregation of a VSX1 mutation adds a new dimension to
its role in the causation of keratoconus
Preeti Paliwal,1 Radhika Tandon,2 Divya Dube,3 Punit Kaur,3 Arundhati Sharma1
1Laboratory of Cyto-Molecular Genetics, Department of Anatomy, All India Institute of Medical Sciences, New Delhi, India; 2Dr.
Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India; 3Department of
Biophysics, All India Institute of Medical Sciences, New Delhi, India
Purpose: To look for segregation of Visual System Homeobox 1 (VSX1) mutations in family members of a patient with
keratoconus.
Methods: Our initial molecular genetic studies conducted to identify the role of VSX1 in the causation of keratoconus had
identified a novel mutation in one patient. He later presented to the clinic affected with vernal kerato conjunctivitis (VKC)
accompanied by his brother, also similarly affected. All the family members were called and detailed clinical evaluations
were undertaken. DNA from the blood samples of all family members was amplified using primers specific for VSX1 and
analyzed by direct sequencing to look for segregation of the mutation in the family members. Protein modeling studies
were done to assess the effect of the mutation on protein structure and function.
Results: Clinical examination of the family revealed bilateral keratoconus and VKC in the proband and his brother. One
of his sisters had VKC without keratoconus and his parents and another sister were normal. Molecular analysis identified
the VSX1 mutation Q175H in the affected brother and in the mother who had neither VKC nor keratoconus but only the
VSX1 Q175H sequence change.
Conclusions: The VSX1 Q175H mutation may be a pathogenic variant with incomplete penetrance. Protein modeling
studies show that the mutation affects the DNA binding properties of the protein. This VSX1 variant exhibiting low
penetrance may require the presence of some modifier genes or environmental factors for disease presentation. VSX1 may
have an important role in the pathogenesis of keratoconus which needs further investigation.
Keratoconus  (KC;  OMIM  148300)  is  a  bilateral,
progressive corneal ectasia characterized by protrusion of the
apical cornea due to thinning, leading to progressive myopia
and irregular astigmatism [1]. Severely affected patients often
require  corneal  transplantation.  The  pathophysiology  of
keratoconus is not completely understood, though various
studies have suggested keratoconus to be associated with eye
rubbing  [2,3]  and  use  of  contact  lenses  [4].  The  other
commonly  associated  ocular  disorders  include  vernal
keratoconjunctivitis [5], retinitis pigmentosa [6], and Leber
congenital amaurosis (LCA) [7]. Various connective tissue
disorders like Ehlers-Danlos and Marfan syndromes are also
known to be associated with keratoconus [8].
Vernal keratoconjunctivitis (VKC) is the inflammation
of cornea and conjunctiva, usually occurring during spring
season. It is considered to be caused by allergens but the role
of several genes is also implicated [9]. A higher incidence of
keratoconus is seen in patients affected with VKC where eye
rubbing is suggested as a possible cause of keratoconus [10].
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Several chromosomal loci and genes are reported to be
associated with the occurrence of keratoconus [11]. One of
the widely studied genes is the Visual System Homeobox 1
(VSX1; OMIM 605020) localized to chromosome 20p11-q11.
The true association of this gene with KC is not yet established
due to the conflicting reports of the various studies which have
been conducted world over [11-13].
We reported a mutation Q175H in VSX1 in an individual
diagnosed with keratoconus. This change was not seen in 100
control individuals who were also analyzed for the underlying
changes in VSX1 [14]. In silico analysis of the change using
SIFT performed previously had given a score of <0.05 which
showed that the change was not tolerated and the glutamine
at  position  175  is  conserved  across  species  [14].  We
subsequently contacted the patient for further detailed study
of the family. We now report the segregation of this change
(Q175H) in the family members of the proband.
METHODS
The study adhered to the tenets of Declaration of Helsinki and
was approved by the Institutional Ethics Committee of All
India Institute of Medical Sciences (AIIMS). The proband
initially presented in the Cornea and Refractive Surgeries
Services  and  Contact  Lens  Clinic  at  Dr.  Rajendra  Prasad
Centre for Ophthalmic Sciences, All India Institute of Medical
Sciences two years back at 19 years of age with diminution of
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481vision for past 8 years and recurrent redness and watering. He
was diagnosed to have KC and molecular analysis revealed a
novel VSX1 mutation in him. He presented to the clinic again
after 2 years with his brother aged 18 years, also affected with
diminution of vision, recurrent redness and watering. Detailed
family history up to three generations was taken and other
family members (parents and two sisters) were called to the
clinic. Informed consent was taken from all the participants
after explaining the nature and possible consequences of study
participation. Detailed clinical examination was performed
for identifying and characterizing keratoconus in the family
members  that  included  corneal  stromal  thinning,  Vogt’s
striae,  Fleischer’s  ring,  Munson’s  sign,  and  corneal
topography, i.e., corneal power (K), inferior–superior dioptric
asymmetry (I-S), astigmatism (Ast), and skewed radial axis
(SRAX) using Orbscan II operating with software version
3.12 (Bausch & Lomb Inc., Rochester, NY) that were used to
calculate KISA% (a single index that quantifies the irregular
corneal shape and astigmatism typical of keratoconus with
good clinical correlation) according to Massachusetts Ear and
Eye Infirmary KC Classification.
DNA extraction and PCR amplification: A total of 5 ml
peripheral blood samples were drawn from the affected and
unaffected family members and genomic DNA was extracted
from peripheral blood leukocytes using standard protocols.
All the five exons and intron/exon boundaries of VSX1 were
amplified using custom-synthesized oligonucleotide primers
as described previously [14] and presented in Table 1. Each
reaction was performed in a 25 μl mixture containing 2.5 μl
10× PCR buffer with 3.5 mM MgCl2, 2.5 mM dNTPs, 10 pM
of each primer, 0.7 U Taq DNA polymerase (Roche, Applied
Biosystems,  Foster  City  CA)  and  100  ng  genomic  DNA.
Thermal cycling was performed in a thermal cycler (Applied
Biosystem 9700; Roche, Applied Biosystems) as described
herein: initial denaturation for 12 min at 95 °C; 35 cycles of
94 °C for 30 s, 62 °C (exons 1–4) or 60 °C (exon 5) for 30 s,
72 °C for 30 s, and a final extension for 10 min at 72 °C.
Sequencing: All the amplified products were sequenced
bidirectionally  using  BigDye  Terminator  Mix  version  3.1
(Applied Biosystems [ABI], Foster City, CA) according to the
manufacturer’s  instructions  and  were  analyzed  on  an
ABI-3100  Genetic  Analyzer  (ABI).  Nucleotide  sequences
were compared with the published VSX1 cDNA sequence
(GenBank NM_014588).
Homology modeling: Protein homology modeling and
Molecular Dynamics (MD) simulations was performed for the
VSX1 Q175H change to assess the structural implications of
this mutation on the protein conformation. VSX1 has 58%
sequence identity with the homeodomain of Drosophila. A
homology model was built using the three-dimensional X-ray
crystal structure of homeodomain (Protein Data Base code:
1FJL)  as  a  template  with  the  model  building  software
Modeller9v7.  Mutant  VSX1  (Q175H)  was  generated  by
altering  corresponding  residue  and  the  resulting  mutated
structures  were  studied  by  applying  molecular  dynamics
simulation using DS 2.0 (Messrs Accelrys, San Diego, CA).
The  structures  of  the  native  protein  and  mutants  were
validated  for  their  accuracy  and  correctness  using
PROCHECK  [15]  and  figures  were  drawn  with  PYMOL
(Molecular Graphics System [2002]; DeLano Scientific, San
Carlos, CA).
Molecular dynamics simulation: To check the effect of
the change on the overall conformation of VSX1, extensive
MD simulations were performed on a fully hydrated model of
both wild type (wVSX1) and mutant (mVSX1). The structures
of  both  wild-type  and  mutant  were  further  analyzed  for
differences induced in the protein conformation due to the
change.
RESULTS
Clinical examination of the proband who had presented at 19
years of age with diminution of vision for past eight years,
recurrent redness, itching and watering had revealed bilateral
keratoconus  (corneal  pachymetry-  OD-432,  OS-448;
simulated  keratometer  value-OD-55.70D,  OS-51.00D).
Clinical evaluation on his successive visit revealed presence
of VKC. His brother, aged 18 years was also found to be
affected  with  keratoconus  (corneal  pachymetry-  OD-452,
OS-460;  simulated  keratometer  value-  OD-48.50D,
OS-55.85D) and VKC. Another sister who was 15 years old
had VKC but no keratoconus (corneal pachymetry- OD-544,
OS-539;  simulated  keratometer  value-  OD-45.20D,
OS-45.00D).  The  parents  (father  55  years  and  mother  50
years) and one sister aged 23 revealed a disease free cornea
(Figure 1). Mutational analysis of VSX1 was performed in all
the family members. The heterozygous change c.525G>C
identified in the patient was seen in the affected brother and
the clinically unaffected mother (The clinical examinations of
TABLE 1. THE VSX1 PRIMER SEQUENCES.




1 5’-CAGCTGATTGGAGCCCTTC-3’ 5’-CTCAGAGCCTAGGGGACAGG-3’ 599 58 °C
2 5’-GCCCACTAAAAATGCAGAA-3’ 5’-GCCTCCTAGGAACTGCAGAA-3’ 393 59 °C
3 5’-CATTCAGAGGTGGGGTGTT-3’ 5’-TCTTGTGGTGCCTTCAGCTA-3’ 419 62 °C
4 5’-GATCATGATCGGGAGAGAAG-3’ 5’-CGTTGCTTTGCTTTGGAAAT-3’ 394 59 °C
5 5’-CCCCAGAGATAGGCACTGAC-3’ 5’-TGGACAATTTTTGTCTTTTGG-3’ 495 59 °C
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482mother  revealed  corneal  pachymetry-  OD-560,  OS-562;
simulated keratometer value- OD-46.50D, OS-47.00D). The
father and the two sisters did not reveal this change.
Protein modeling: A comparison of the conformations in
the  wild  type  and  mutant  VSX1  revealed  a  variation  in
intermolecular interactions involving hydrogen bonds. Due to
the Q175H mutation the polar glutamine residue is converted
to the basic imidazole ring containing histidine which results
in the complete disruption of hydrogen bonds involving the
Gln175 Oε1 – Thr172 Oγ1 and Gln175 Nε2 – Thr201 O
interactions in the mutant protein (Figure 2). Moreover, the
Thr201, Glu178, Ala173, and Thr172 side chains were also
pushed  back  due  to  the  presence  of  a  more  bulky  and
positively charged side chain of His175 in the mutant protein.
These  resulting  differences  in  the  interaction  due  to  the
mutation alter the loop conformations in the regions involving
residues Thr169- Leu179 and Leu197 – Ile208 (Figure 3). The
threonine  residue  at  position  201  along  with  neighboring
residues and NH2-terminal residues like Thr172 are critical
for  specificity  of  DNA-binding.  These  conformational
differences in the backbone of the molecule are localized to
the regions around amino acid position 175 and the resulting
changes possibly hinder the DNA/protein interactions.
DISCUSSION
We found a VSX1 Q175H change in the proband and his
affected brother. Familial segregation of the disease revealed
the  mutation  Q175H  to  be  present  in  affected  as  well  as
unaffected family members. The molecular modeling studies
showed  that  this  mutation  causes  loss  of  molecular
interactions leading to localized conformational changes in
the protein affecting its DNA binding capacity proving its role
in disease causation.
The resulting phenotype in turn may be dependent on the
interaction of VSX1 with some modifier genes and/or the
environment. Several genetic variants of VSX1 have been
described but their pathogenicity is doubtful. This gene was
initially studied by Héon et al. [13] identifying the association
of posterior polymorphous corneal dystrophy (PPCD) and
keratoconus. One of the variants identified in their study,
D144E was seen in an individual with PPCD and keratoconus
and also in an individual with glaucoma without any corneal
defect.  The  D144E  mutation  was  initially  reported  as
pathogenic but subsequent studies identified its presence in
unaffected  individuals  also  suggesting  this  to  be  a
polymorphism [11].
Figure  1.  Pedigree  of  the  family
showing  the  heterozygous  VSX1  c.
525G>C  (Q175H)  nucleotide  change.
Filled  symbols  represent  individuals
affected  with  keratoconus  and  open
symbols  represent  unaffected
individuals.  The  arrow  indicates  the
proband, the sign ‘+’ represents the wild
type  and  Q175H  is  the  mutation
detected.
Figure  2.  Close  view  of  the  VSX1
Q175H  mutation  area.  The  hydrogen
bond interactions are marked for clarity
in  the  wild  type  (A,  cyan)  and  their
disruption  in  the  mutant  (B,  green)
proteins.
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483Likewise there have been several studies on the genetic
variants of VSX1 but the pathogenicity could not always be
confirmed  as  their  segregation  was  also  seen  in  some
unaffected individuals [14].
There can be several explanations to the presence of the
VSX1 Q175H change observed in our family. It could be a
non-disease causing change that randomly appeared in this
family in both affected (two brothers) as well as unaffected
(mother) members. However its absence in 100 controls, in
silico analysis [14] and molecular modeling studies suggested
this to be a pathogenic change. Nevertheless, the possibility
of this being a rare polymorphism still exists and screening of
more controls and different populations is needed to ascertain
its true nature. Another important feature is that the observed
change may be pathogenic but with incomplete penetrance.
The presence of this change in the unaffected mother suggests
that  this  could  be  a  causative  mutation  with  incomplete
penetrance.
The change can otherwise be explained based on the
presence  of  mutation  and  the  allergic  disorder  VKC–  the
Figure  3.  Altered  loop  conformations  in  the  regions  involving
residues Thr169- Leu179 and Leu197 – Ile208 because of mutation
in the mutant (green) as compared to wild type (cyan) proteins.
patients  may  be  more  susceptible  for  KC  as  seen  in  the
proband and his brother. The mother who also had the same
change  but  did  not  have  VKC  did  not  develop
keratoconus.The  sister  who  had  VKC  but  did  not  have
mutation in VSX1 did not manifest the disease. So, the Q175H
mutation may not directly cause the disease but does so only
in  presence  of  another  associated  disorder.  A  probable
explanation could be that the change in heterozygous state
may not be truly pathogenic with one normal copy enough to
perform its role in the individual. With changes in other genes,
or the environment this single copy becomes insufficient and
in turn may result in keratoconus. This can also be emphasized
from the fact that in patients with LCA, mutations in the
Crumbs  homolog  1  (CRB1)  gene  were  seen  to  cause
keratoconus  [7].  Initial  reports  were  also  based  on  the
presence  of  VSX1  mutations  in  patients  with  posterior
polymorphous dystrophy (PPCD) and keratoconus, so it may
be hypothesized that in presence of another associated disease
condition the genetic variants of VSX1, or other associated
genes  makes  the  individuals  more  susceptible  to  develop
keratoconus.
The studies conducted on VSX1 either excluded or did not
describe other associated abnormalities seen in their patients.
These exclusions can alter the actual consequences of the
variations observed in VSX1, as the gene and the coded protein
may have a minor role by themselves but can cause significant
damage in association with other genes or the environment.
This explanation will even hold true for the various VSX1
variants exhibiting low penetrance by themselves but playing
a significant role in the presence of modifier genes.
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